This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barletta, G. Articles by Franchi, F. Search for Related Content PubMed PubMed Citation Articles by Barletta, G. Articles by Franchi, F.

Cardiovascular Effects of Parathyroid Hormone: A Study in Healthy Subjects and Normotensive Patients with Mild Primary Hyperparathyroidism¹

Department of Internal Medicine (C.L., S.V., G.L.V., F.F.), Endocrine Unit, Department of Clinical Physiopathology (M.L.D.F., M.L.B.), University of Florence Medical School; and Cardiovascular Echography Unit (G.B., R.D.B.), Azienda Ospedaliera Careggi, 50139 Firenze, Italy

Address correspondence and requests for reprints to: Maria Luisa Brandi, M.D., Department of Clinical Physiopathology, University of Florence, Viale Pieraccini, 6, 50139 Firenze, Italy.

The aim of the study was to evaluate: 1) the cardiovascular function and the autonomic drive to the heart in patients affected by primary hyperparathyroidism (pHPT) with no evidence of renal and cardiovascular complications; 2) the cardiovascular effects of acute administration of PTH in normal subjects. In 14 patients affected by mild asymptomatic pHPT echocardiographic assessment of cardiovascular function and of the mechanic properties of the brachial and carotid artery, heart rate variability and the dispersion of QT interval were performed before and 6 months after successful surgery. Twenty age- and sex-matched healthy subjects were included in the study. Five healthy volunteers underwent a single blind, placebo-controlled, random order, cross-over study with infusion of PTH (hPTH 1–34, 200 U in saline over 5 min) or placebo. Ecocardiographic assessment of cardiovascular function, heart rate variability, and QT interval were performed between 20 and 25 min after the start of the infusion and repeated after 15 min of tilting at 60 degrees.

In pHPT patients the echocardiographic parameters were normal; left ventricular isovolumetric relaxation time was always in the normal range, but significantly shorter than in control subjects, suggesting an increased sympathetic stimulation. Arterial diameters and thickness, blood pressure, and QT interval were not significantly different with respect to normal subjects and were unchanged 6 months after surgery. pHPT patients lacked the circadian rhythm of the low frequency to high frequency ratio, suggesting an increased sympathetic drive to the heart at nighttime. In normal subjects there were no significant differences in basal echocardiographic measurements during PTH infusion with respect to placebo and in the hemodynamic response to tilt.

These results suggest that cardiovascular function is substantially normal in normotensive pHPT patients with mild hypercalcemia. A modulation of the adrenergic control of circulation seems to be associated with hypercalcemia and/or chronic PTH excess, but its biological relevance needs further investigations.

This article has been cited by other articles:

				M. R. Rubin, M. S. Maurer, D. J. McMahon, J. P. Bilezikian, and S. J. Silverberg Arterial Stiffness in Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3326 - 3330. [Abstract] [Full Text] [PDF]

				P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF]

				F.N Saleh, H Schirmer, J Sundsfjord, and R Jorde Parathyroid hormone and left ventricular hypertrophy Eur. Heart J., November 2, 2003; 24(22): 2054 - 2060. [Abstract] [Full Text] [PDF]

				G. de Simone Left Ventricular Geometry and Hypotension in End-Stage Renal Disease: A Mechanical Perspective J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2421 - 2427. [Abstract] [Full Text] [PDF]

				H. Ogata, E. Ritz, G. Odoni, K. Amann, and S. R. Orth Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors J. Am. Soc. Nephrol., April 1, 2003; 14(4): 959 - 967. [Abstract] [Full Text] [PDF]